Breakfast Satellite: Complex PCI – Nothing Is Simple in Shock Patients!

Chipping Away – Calcium Modification in Complex PCI

Saraschandra Vallabhajosyula, MD MSc, FSCAI

CTO’s in AMI-Shock – When and How to Treat

Rhian E. Davies, DO MS, FSCAI

Getting In and Out Safely - Vascular Access and Closure in AMI-CS

Vikas Aggarwal, M.B.B.S., FSCAI

Introductory Remarks

Behnam N. Tehrani, M.D.

Keeping Your Eyes Open – Role of Intravascular Imaging in Complex PCI

Hayder D. Hashim, M.D., FSCAI

To Support or Not to Support – MCS in AMI-Shock

Behnam N. Tehrani, M.D.

What is Complex and High Risk? – Patient Population and Tools/Skillsets Needed to Treat

Vicente Jimenez-Franco, MD

Breakfast Session: Mapping the Maze of Cardiogenic Shock – Shock Phenotypes, Stages, and Hemodynamics

IABP: Inflated Hopes or Deflated Use? SCAI Staging and Cardiogenic Shock Controversies in Clinical Trials

Shashank S Sinha, MD, MSc

One Shock Doesn’t Fit All - Cardiogenic Shock Phenotypes

Michael A Solomon, MD MBA

SCAI DLC Initiative: Definition, Hypothesis and Call to Action

Srihari S. Naidu, MD, MSCAI

Shocking Developments: Hemodynamics & Treatment in CS

Howard A Cooper, M.D.

Breakout Session – The Advanced Practitioner's Role in the Critical Care Unit

Benefits of Having APPs in the ICU: From a Surgeon/HF Attending Perspective

Duc Thinh T Pham, MD

Discussion

Expanding Into an MCS APP Team

Colleen LaBuhn

How to Utilize APPs in an ICU

Katie Dye, MSN

Investing in APPs in the ICU

Mr. Andrew Shunk, MHA

Breakout Session – The People’s Ventricle: Right Ventricular Cardiogenic Shock

CICU Management of RV-Predominant Cardiogenic Shock

Eric P Cantey, MD, FSCAI

Epidemiology and Initial Medical Management of RV Shock

Vicente Jimenez-Franco, MD

MCS for Treatment of RV-Predominant Cardiogenic Shock

Said Ashraf, MD, FSCAI

RV Shock Due to CTEPH: BPA vs. Surgery

Vikas Aggarwal, M.B.B.S., FSCAI

Breakout Session – This Job is Stressful! Maintaining Your Own Wellbeing

Can I Prevent Moral Injury and Compassion Fatigue?

Joaquin E. Cigarroa, M.D., MSCAI

Dealing with Complications and Unexpected Outcomes

Frank J. Amico Jr., D.O.

Don’t Suffer in Silence: Finding a Support Network

David Howard

The Second Victim Syndrome

Kimberly A. Skelding, M.D., FSCAI

Breakout Session: The Shock Coordinator Playbook – Practical Strategies for Optimal Care

Building a Shock Network: Connecting Care Inside and Out

Vika Kagan, ARNP, MSN

Shock Case Review: Turning Data into Impactful Care

Robyn Mitchell, DNP, ACNPC-AG, E-AEC

Shock Coordinators 101: Navigating the Frontlines of Cardiogenic Shock Care

Stephanie Koepke, MSN, ACNS-BC

Shock Tracking: Harnessing the Right Tools for Better Outcomes

Charlie Nix

Challenging Shock Cases: Escalation and De-escalation

CASE: AMI Shock with Escalation to Impella 5.5

Ilan Vavilin, MD

CASE: HF-CS

Arushi Singh, MD, MSc

Dinner Program: ECMO Workshop – When and How to Use a Powerful Tool

Introductory Remarks

Allison G. Dupont, M.D., FSCAI

Tips for Safe Cannulation

Allison G. Dupont, M.D., FSCAI

Venoarterial ECMO Indications

Amy Hackmann, MD

Getting Your Hospital Administrators on Your Team

Finances of ECMO

John R Mehall, MD

How to get Support From the C- Suite

Ruth Fisher, MBA

Optimizing Hub and Spoke Model: The Financial Benefits of a Shock Program

Mr. Andrew Shunk, MHA

Physician Compensation Models / RVUs and Shock Call

Colleen LaBuhn

Lunch Program: Optimizing Antiplatelet Therapy in Cardiogenic Shock

Case Continuation and Conclusion

Michele L Esposito, M.D., FSCAI

Case Presentation and Initial Clinical Course

Michele L Esposito, M.D., FSCAI

Concluding Remarks and Polling Questions

Sandeep Nathan, M.D., FSCAI

Data for use of Cangrelor in AMI-CS and High-Risk PCI

Jennifer A Rymer, MD, MBA, MHS

Introductory Remarks and Polling Questions

Sandeep Nathan, M.D., FSCAI

Optimal Antiplatelet Strategies in High-risk Patients

Srihari S. Naidu, MD, MSCAI

Pharmacodynamics of Antiplatelet Therapies With and Without CS

Frank J. Amico Jr., D.O.

Lunch Satellite: Management of Shock in Patients With Pulmonary Embolism (CME)

Choosing the Right Treatment for the Right PE Patient

Oren Friedman, MD

Introductory Remarks

Vikas Aggarwal, M.B.B.S., FSCAI

Mechanical Circulatory Support in Pulmonary Embolism

Allison G. Dupont, M.D., FSCAI

Normotensive Does Not Mean Low Risk: Insights from the FLASH Registry

Sripal Bangalore, MD, MHA, FSCAI

Questions Remaining Unanswered in Published Thrombectomy Trials, Where Do We Go from Here?

Said Ashraf, MD, FSCAI

What Role does a Surgeon Have on the PERT Team?

Amy Hackmann, MD

Managing Cardiogenic Shock in Patients with Valvular Heart Disease

At the Intersection of Valvular Disease and Cardiogenic Shock – Common Clinical Scenarios and Contemporary Outcomes

Ioana Dumitru

CASE 1: Critical AS and Cardiogenic Shock

Hiram G Bezerra, M.D., Ph.D.

CASE 2: Emergent M-TEER for Severe MR and Cardiogenic Shock

Rebecca Chester, MD

Systems of Care in Cardiogenic Shock: Teams, Networks and Post Discharge Management

CS Management in 2025: Optimizing CICU Staffing Models

Saraschandra Vallabhajosyula, MD MSc, FSCAI

From Shock Teams to Shock Networks: The Hub and Spoke Model

Behnam N. Tehrani, M.D.

Shock Survivorship: The Role of Cardiogenic Shock Clinics Post-Hospital Discharge

Iyad N Isseh, MD

Time is Tissue: EMS and ED Protocols for the Shock Patient

Dr. Aditya Bharadwaj, M.B.B.S., FSCAI

When to Call the Shock Team: Protocol Dissemination in the Community

David A. Baran, M.D., FSCAI

Top Shock Cases

Cardiac Arrest During Acute MI Revascularization: Mobile VA-ECMO and Progressive Mechanical Support Enable Survival

Robby Wu, DO, FACC

Regurgitation, Reperfusion, Rescue: ECMO in the Setting of Aortic Valve Catastrophe

Shazil Mahmood, MD

VA-ECMO as a Bridge to Transplant Following Apical Wall Rupture

Hannah Every, MD

2025 SCAI SHOCK

2025 SCAI SHOCK: Alphabetical Content Listing